Michael Schmid is a research group leader at the Institute of Translational Medicine, University of Liverpool, UK. He initially studied biology at the University of Bern, Switzerland and completed his Masters at the Institute of Immunology in Bern. He next moved to Basel, Switzerland, for his PhD training at the Biozentrum. After completion of his PhD, he received a postdoctoral fellowship and he moved to California, to carry out his postdoctoral training at the Moores Cancer Center, University of California, San Diego (UCSD) in the group of Prof Judith Varner. At the Moores Cancer Centre, Michael’s research focused on the recruitment of myeloid cells to the tumour microenvironment and how tumour inflammation affects cancer progression. In 2012 Michael Schmid moved to the University of Liverpool, UK, to establish an independent research group in cancer medicine.
Michael’s lab now pursues a research programme on the tumour microenvironment in pancreatic cancer metastasis. The main goal of his team is to gain a better understanding of where, when and how host immune cells enhance or suppress metastatic progression in pancreatic cancer, with the ultimate aim of identifying new therapeutic possibilities to fight pancreatic cancer.
PhD-degree (summa cum laude), University of Basel, Switzerland, 2005.
Master in Biology, University of Bern,
For more information, please visit our lab website www.schmidlab.org